The Duke Molecular Physiology Institute (DMPI) works with people throughout the world in its quest to understand human diseases. Patients and families participate in studies that will add to the body of knowledge about a wide range of disorders.
Using the links below, you can learn about the studies currently under way at the DMPI.
All of our work is done with a fundamental respect for patients and their privacy. The Duke Health Enterprise Notice of Privacy Practices (NPP) brochure describes how patient medical information may be used and disclosed and how patients can get access to this information. The NPP brochure is available to all participants enrolled in our studies.
- Amyotrophic Lateral Sclerosis (ALS)
- Chiari Type 1 Malformation
- Familial Focal Segmental Glomerulosclerosis (FSGS)
- Multiple Sclerosis (MS)
- Neural Tube Defects (NTD)
- Sickle Cell Disease (SCD)
- A Study to Identify the Diagnostic and Prognostic Biomarkers of Disease Development and Progression in Multiple Sclerosis
- Ghrelin Effect on Beta Cell Function in Health and Disease
- Role of alpha-cell GLP-1 in the beta-cell response to DPP-4 inhibition
- Open-label Study to Assess the Safety of Repeat Administration of FX006 to Patients with Osteoarthritis of the Knee
PROTOCOLS IN DEVELOPMENT